Clinical Trials Logo

Clinical Trial Summary

Preimplantation genetic diagnosis (PGD) is an assisted reproductive technology (ART) by which embryos, created through in vitro fertilization (IVF), can be screened for genetic conditions or traits before they are implanted into a woman s uterus. Within the past few years, a controversial non-medical use of PGD has gained recognition as having possible significant ethical implications. Non-medical sex selection (NMSS) describes the use of PGD technology to choose the sex of a child for social, as opposed to medical, reasons. In the US and a select few other countries, it is legal to use NMSS for family balancing, or the intentional selection of an underrepresented sex to balance a family where the majority of the children are of one sex. Proponents of family balancing believe that NMSS is an expression of reproductive autonomy and is ethically acceptable on those grounds. Opponents are more likely to cite beneficence (toward the existing children and the potential future child) and justice (resource allocation and access, for example) as the basis for concerns around NMSS and family balancing specifically. In the US and other countries, healthcare providers (HCPs) are often the gatekeepers to this technology. There is little research exploring the experiences of HCPs with PGD and NMSS. The Moral Experience framework (Hunt and Carnevale, 2011) is useful for understanding the potential concerns of HCPs as well as their feelings and behaviors evoked by lived and hypothetical experiences around NMSS. Also of interest is how HCPs feel that decisions about NMSS are made and their preferences as to how they should be made. Finally, there is concern that NMSS may be the first in a line of non-medical uses for PGD and that a slippery slope toward what some describe as designer babies will follow. We are interested in eliciting the traits that HCPs believe are hypothetically appropriate or inappropriate for PGD and how they make the distinction. Interviews with HCPs (OBGYNs and reproductive endocrinologists) on these topics will be transcribed and subjected to thematic analysis in order to identify common themes. An understanding of the experiences and attitudes of this stakeholder population can help clarify current issues at individual, societal, and global levels and future directions for research and policy....


Clinical Trial Description

Preimplantation genetic diagnosis (PGD) is an assisted reproductive technology (ART) by which embryos, created through in vitro fertilization (IVF), can be screened for genetic conditions or traits before they are implanted into a woman s uterus. Within the past few years, a controversial non-medical use of PGD has gained recognition as having possible significant ethical implications. Non-medical sex selection (NMSS) describes the use of PGD technology to choose the sex of a child for social, as opposed to medical, reasons. In the US and a select few other countries, it is legal to use NMSS for family balancing, or the intentional selection of an underrepresented sex to balance a family where the majority of the children are of one sex. Proponents of family balancing believe that NMSS is an expression of reproductive autonomy and is ethically acceptable on those grounds. Opponents are more likely to cite beneficence (toward the existing children and the potential future child) and justice (resource allocation and access, for example) as the basis for concerns around NMSS and family balancing specifically. In the US and other countries, healthcare providers (HCPs) are often the gatekeepers to this technology. There is little research exploring the experiences of HCPs with PGD and NMSS. The Moral Experience framework (Hunt and Carnevale, 2011) is useful for understanding the potential concerns of HCPs as well as their feelings and behaviors evoked by lived and hypothetical experiences around NMSS. Also of interest is how HCPs feel that decisions about NMSS are made and their preferences as to how they should be made. Finally, there is concern that NMSS may be the first in a line of non-medical uses for PGD and that a slippery slope toward what some describe as designer babies will follow. We are interested in eliciting the traits that HCPs believe are hypothetically appropriate or inappropriate for PGD and how they make the distinction. Interviews with HCPs (OBGYNs and reproductive endocrinologists) on these topics will be transcribed and subjected to thematic analysis in order to identify common themes. An understanding of the experiences and attitudes of this stakeholder population can help clarify current issues at individual, societal, and global levels and future directions for research and policy. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02225171
Study type Observational
Source National Institutes of Health Clinical Center (CC)
Contact
Status Completed
Phase
Start date August 23, 2014
Completion date December 31, 2014

See also
  Status Clinical Trial Phase
Completed NCT03572322 - Genetics Tests : How to Improve Management Within Two Medical Specialities
Recruiting NCT05394363 - Generation Victoria Cohort 2020s: A Statewide Longitudinal Cohort Study of Victorian Children and Their Parents
Completed NCT00340509 - A Genome-Wide Scan For Quantitative Trait Loci of Serum Bilirubin - A Framingham Study
Recruiting NCT02671253 - Myomectomies:Tumor Characteristics and Clinical Implications N/A
Completed NCT01317134 - Endothelial Function in Patients With Pulmonary Arterial Hypertension N/A
Completed NCT03973060 - Effectiveness of Muscular Work and Genetic Variants in Strength Gain of Ischiofemoral and Quadriceps N/A
Terminated NCT02566161 - Parental Irradiation of Ukrainian Cleanup Workers and Evacuees and Germline Mutations in Their Offspring (Trio Study)
Terminated NCT01375556 - Genetics of the Acute Response to Alcohol in Social Drinkers Phase 1
Recruiting NCT00418912 - Family Study in Schizophrenia N/A
Completed NCT03446079 - Relationship of Skin Related SNP to Topical Skin Care Product N/A
Recruiting NCT04024631 - Phenotyping Genetic Risk for Type 2 Diabetes N/A
Completed NCT00339924 - Physicians' Understanding of Human Genetic Variation
Not yet recruiting NCT05851209 - Biomarkers and Mechanisms of Disease Progression and Outcome of Aortic Stenosis in Humans
Completed NCT03301519 - Genetics of Beta Cell Failure in Mexican Americans
Completed NCT01294345 - Personalized Genomic Research
Recruiting NCT03650829 - IVF Offspring Born in Guangzhou
Recruiting NCT06239077 - Identifai Genetics Analytic Validity Study - Compound Heterozygosity and Samples Collection N/A
Not yet recruiting NCT04038281 - Genetics of Bitter and Fat Taste
Completed NCT03572205 - Fatty Acid Desaturase Gene Locus Interactions With Diet (FADSDIET2) N/A
Recruiting NCT03221322 - How do Super Lean Subjects Keep Resistant to Body Weight Gain?